Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age
Titel:
Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age
Auteur:
Diaz-Mitoma, Francisco Halperin, Scott A. Tapiero, Bruce Hoffenbach, Agnes Zappacosta, Pamela S. Radley, David Bradshaw, Susan Martin, Jason C. Boslego, John W. Hesley, Teresa M. Bhuyan, Prakash K. Silber, Jeffrey L.